Ampio Pharma(AMPE.US)

Company Encyclopedia

Ampio Pharma

AMPE.US

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.

4.691 T

AMPE.USMarket value -Rank by Market Cap -/-

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
Cypress Capital Management, LLC	0.04%	No Change	30/09/2025
Wealth Preservation Advisors, LLC	0%	No Change	30/09/2025
Luminist Capital, LLC	0%	No Change	30/09/2025

News

Ampio Announces Notice of Proposed Settlement of Stockholder Derivative Actions and Settlement Hearing

Ampio Pharmaceuticals, Inc. has announced a proposed settlement regarding stockholder derivative actions. The settlement, which requires court approval, aims to resolve claims against certain current and former directors and officers. If approved, current stockholders will be barred from contesting the settlement. The company will implement certain reforms and pay $500,000 in attorneys' fees, subject to court approval. A hearing will be held to assess the fairness of the settlement. This notice serves to inform stockholders of their rights related to the proposed settlement.

Reuters·01/30/2025 01:40

AMPE

0.00%

Reuters·01/30/2025 01:40

AMPE

0.00%